- Home
- CRIS vs APCX Comparison
CRIS vs APCX Comparison
Compare CRIS & APCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- APCX
- Stock Information
- Founded
- CRIS 2000
- APCX 2006
- Country
- CRIS United States
- APCX United States
- Employees
- CRIS N/A
- APCX N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- APCX Finance: Consumer Services
- Sector
- CRIS Health Care
- APCX Finance
- Exchange
- CRIS Nasdaq
- APCX Nasdaq
- Market Cap
- CRIS 13.5M
- APCX 12.0M
- IPO Year
- CRIS 2000
- APCX N/A
- Fundamental
- Price
- CRIS $1.96
- APCX $0.27
- Analyst Decision
- CRIS Strong Buy
- APCX
- Analyst Count
- CRIS 3
- APCX 0
- Target Price
- CRIS $21.00
- APCX N/A
- AVG Volume (30 Days)
- CRIS 99.1K
- APCX 218.1K
- Earning Date
- CRIS 05-06-2025
- APCX 05-20-2025
- Dividend Yield
- CRIS N/A
- APCX N/A
- EPS Growth
- CRIS N/A
- APCX N/A
- EPS
- CRIS N/A
- APCX N/A
- Revenue
- CRIS $11,202,000.00
- APCX $276,000.00
- Revenue This Year
- CRIS $4.67
- APCX N/A
- Revenue Next Year
- CRIS $9.77
- APCX N/A
- P/E Ratio
- CRIS N/A
- APCX N/A
- Revenue Growth
- CRIS 14.17
- APCX N/A
- 52 Week Low
- CRIS $1.02
- APCX $0.31
- 52 Week High
- CRIS $16.93
- APCX $1.49
- Technical
- Relative Strength Index (RSI)
- CRIS 50.58
- APCX 40.10
- Support Level
- CRIS $1.85
- APCX $0.26
- Resistance Level
- CRIS $2.25
- APCX $0.28
- Average True Range (ATR)
- CRIS 0.27
- APCX 0.04
- MACD
- CRIS 0.04
- APCX -0.00
- Stochastic Oscillator
- CRIS 41.73
- APCX 18.22
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About APCX AppTech Payments Corp.
AppTech Payments Corp is a FinTech company utilizing various payment processing and digital banking technologies to complement core merchant services capabilities. The company's patented and proprietary software will provide progressive and adaptable products that are available through a suite of synergistic offerings directly to merchants, banking institutions, and business enterprises. It is developing a secure digital payment and banking platform that powers commerce experiences for clients and customers. Based upon industry standards for payment and banking protocols, the company will offer standalone products and fully integrated solutions that deliver unparalleled payments, banking, and financial services experiences.